Reply to Kumar and Kulkarni
- PMID: 33284185
- DOI: 10.14309/ajg.0000000000001067
Reply to Kumar and Kulkarni
Comment on
-
Liver Enzyme Elevation in Coronavirus Disease 2019: A Multicenter, Retrospective, Cross-Sectional Study.Am J Gastroenterol. 2020 Jul;115(7):1075-1083. doi: 10.14309/ajg.0000000000000717. Am J Gastroenterol. 2020. PMID: 32618658 Free PMC article.
-
Elevated Liver Chemistries in COVID-19-Is It Not a Concern?Am J Gastroenterol. 2021 Feb 1;116(2):424. doi: 10.14309/ajg.0000000000000914. Am J Gastroenterol. 2021. PMID: 32947321 Free PMC article. No abstract available.
References
-
- Kumar K, Kulkarni A. Elevated liver chemistries in COVID-19-is it not a concern? Am J Gastroenterol 2021;116(2):422.
-
- Hao SR, Zhang SY, Lian JS, et al. Liver enzyme elevation in coronavirus disease 2019: A multicenter, retrospective, cross-sectional study. Am J Gastroenterol 2020;115:1075–83.
-
- Kwo PY, Cohen SM, Lim JK. ACG clinical guideline: Evaluation of abnormal liver chemistries. Am J Gastroenterol 2017;112:18–35.
-
- Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 2018;67:1560–99.
-
- Hundt MA, Deng Y, Ciarleglio MM, et al. Abnormal liver tests in COVID-19: A retrospective observational cohort study of 1827 patients in a major U.S. Hospital network. Hepatology doi: 10.1002/hep.31487). [Epub ahead of print. July 29, 2020.] - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
